Champions Oncology, Inc. (CSBR) - Comprehensive Stock Analysis & Investment Research
Deep dive into Champions Oncology, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Champions Oncology, Inc. Investment Summary
When evaluating whether Champions Oncology, Inc. (CSBR) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Champions Oncology, Inc. (CSBR) operates within the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. The company employs approximately 198 people. With a market capitalization of $84 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Our comprehensive financial analysis covers Champions Oncology, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Champions Oncology, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Champions Oncology, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Champions Oncology, Inc. (Stock Symbol: CSBR) is a prominent company operating within the Life Sciences sector, with a specific focus on the Biological Products, (No Diagnostic Substances) industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Champions Oncology, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Champions Oncology, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Champions Oncology, Inc....
Revenue & Growth Analysis
Champions Oncology, Inc. generates annual revenues of $58 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Champions Oncology, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Champions Oncology, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Champions Oncology, Inc....
Strategic Market Position
Champions Oncology, Inc. strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Champions Oncology, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $1 million annually , with year-over-year cash flow growth of 56.0%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 28.4% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.
Operating margin of -55.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 1.59x indicates exceptional efficiency in utilizing company assets to generate revenue. High asset turnover is characteristic of retail, distribution, or service businesses that operate with relatively lean asset bases. This efficiency translates to higher returns on invested capital when combined with reasonable margins.
Financial Strength & Leverage
Current ratio of 1.15 suggests tight liquidity where current assets just cover current liabilities. This may be efficient but leaves limited cushion for unexpected needs.